GLP1R and type 2 diabetes mellitus: Our model reveals clinical features that should be considered when deciding to initiate GLP-1 M combined therapy for the treatment of T2D, including age, race, T2D duration, HbA1C levels, BMI, hypertension, and the presence or absence of heart failure or retinopathy.